What AtriCure, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 10 | 17 |
| Total trades | 13 | 62 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 25,000 | 575,938 |
| Disposed | 79,568 | 305,409 |
| Net activity | −54,568 | +270,529 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Privitera Salvatore | Chief Technical Officer | Sep 23 | Disclosed 10b5-1 sale · S | −4,519 | $60.00 | −$271K | 142,745 |
| Groves Regina E | Director | Sep 11 | Open-market sale · S | −5,313 | $54.22 | −$288K | 34,546 |
| Privitera Salvatore | Chief Technical Officer | Sep 08 | Disclosed 10b5-1 sale · S | −3,657 | $55.00 | −$201K | 147,264 |
| Privitera Salvatore | Chief Technical Officer | Sep 02 | Disclosed 10b5-1 sale · S | −7,763 | $52.50 | −$408K | 150,921 |
| Dahlquist Karl S. | Chief Legal Officer | Aug 24 | Open-market sale · S | −9,370 | $48.89 | −$458K | 87,319 |
| Prange Karen | Director | Aug 05 | Open-market sale · S | −3,564 | $38.80 | −$138K | 22,809 |
| Yuen Maggie | Director | Aug 05 | Open-market sale · S | −3,500 | $38.42 | −$134K | 14,015 |
| Carrel Michael H | President, CEO, & Director | Jul 30 | Gift · G | −4,000 | — | — | 774,434 |
| Carrel Michael H | President, CEO, & Director | Jul 30 | Gift · G | −700 | — | — | 778,434 |
| Noznesky Justin J | Chief Mktg & Strategy Officer | Jul 29 | Open-market sale · S | −6,182 | $38.80 | −$240K | 100,219 |
| Wehrwein Sven | Director | Jul 28 | Open-market sale · S | −25,000 | $37.84 | −$946K | 40,518 |
| Wehrwein Sven | Director | Jul 28 | Exercise / conversion · M | +25,000 | $19.95 | +$499K | 65,518 |
| Doraiswamy Vinayak | Chief Scientific Officer | Jul 28 | Open-market sale · S | −6,000 | $38.88 | −$233K | 86,511 |
| Privitera Salvatore | Chief Technical Officer | Jun 30 | Grant / award · A | +636 | $23.78 | +$15.1K | 158,684 |
| Seith Douglas J | Chief Operating Officer | Jun 30 | Grant / award · A | +527 | $23.78 | +$12.5K | 229,867 |
| Dahlquist Karl S. | Chief Legal Officer | Jun 30 | Grant / award · A | +636 | $23.78 | +$15.1K | 96,689 |
| Doraiswamy Vinayak | Chief Scientific Officer | Jun 30 | Grant / award · A | +636 | $23.78 | +$15.1K | 92,511 |
| Carrel Michael H | President, CEO, & Director | Jun 30 | Grant / award · A | +636 | $23.78 | +$15.1K | 779,134 |
| Prange Karen | Director | May 20 | Open-market sale · S | −3,000 | $28.65 | −$86K | 26,373 |
| Telman Deborah H | Director | May 18 | Grant / award · A | +6,144 | — | — | 28,328 |
Loading...
